Revenue Decline Driven by Modest Volume Softness
Net sales declined 0.8% YoY to $1.673B in Q2 FY2026 from $1.686B in the prior-year period, suggesting modest volume or pricing headwinds across CLX's product portfolio.
来源: 10-Q Income Statement
该报告暂无中文版，以下为英文版分析。
按公开的固定规则计算，不是模型的主观判断——但其中一项输入（高等级风险的条数）取自下方的 AI 分析。
非投资建议，也不是目标价——评的是本季基本面，不是股价。 完整方法论 →
AI核心结论
CLX reported Q2 FY2026 revenue of $1.67B, down 0.8% YoY, with net income falling 18.7% to $157M amid rising liabilities and a deepening negative stockholders' equity position.
营收
16.73亿美元
同比 -0.77%
每股收益（稀释）
1.29美元
同比 -16.23%
毛利率
43.2%
同比 -0.6 个百分点
SEC XBRL 原值
Clorox (CLX) Q2 FY2026 营收 16.73亿美元，同比下降 0.8%。 CLX 的财年 Q2 FY2026 对应日历 Q4 2025。
近 4 个季度：2 次超预期
| 季度 | 实际 EPS（美元） | 市场预期（美元） | 结果 |
|---|---|---|---|
| 2026年6月 | 1.66 | 1.67 | 不及预期 -0.5% |
| 2026年3月 | 1.64 | 1.57 | 超预期 +4.7% |
| 2025年12月本次财报 | 1.39 | 1.45 | 不及预期 -4.0% |
| 2025年9月 | 0.85 | 0.79 | 超预期 +7.0% |
2025年12月 调整后（非 GAAP） EPS 1.39美元，分析师一致预期 1.45美元，不及预期 -4.0%。 分析师一致预期按市场通行的调整后（非 GAAP）口径。本季 GAAP 稀释每股收益为 1.29美元。
由 AI 基于本次 SEC 报告整理
Net sales declined 0.8% YoY to $1.673B in Q2 FY2026 from $1.686B in the prior-year period, suggesting modest volume or pricing headwinds across CLX's product portfolio.
来源: 10-Q Income Statement
Gross margin contracted approximately 62 basis points YoY to 43.16% from 43.77%, as cost of revenue rose 0.3% despite lower sales, reflecting input cost pressures that offset SG&A savings.
来源: 10-Q Income Statement & Key Ratios
SG&A expenses declined 6.4% YoY to $262M and R&D fell 6.5% to $29M, demonstrating active cost management efforts that partially cushioned the impact of gross margin pressure on operating results.
来源: 10-Q Income Statement
Fiscal year-to-date operating cash flow reached $404M, up 0.7% from $401M in the same prior-year period, indicating the business continues to generate solid cash despite earnings pressure.
来源: 10-Q Cash Flow Statement (YTD)
Current liabilities surged 35.7% YoY to $2.347B from $1.730B, driving the current ratio down to 0.74 and deepening the negative stockholders' equity to -$125M, signaling elevated near-term financial obligations.
来源: 10-Q Balance Sheet
由 AI 基于本次 SEC 报告整理 · 高 2 中 3 低 0
CLX's stockholders' equity deteriorated to -$125M from -$41M a year ago, a decline of over 200% YoY, while total liabilities reached $5.578B. The debt-to-equity ratio is deeply negative at -44.6x, reflecting a highly leveraged balance sheet that limits financial flexibility.
来源: 10-Q Balance Sheet
Current liabilities jumped 35.7% YoY to $2.347B while current assets grew only 5.9% to $1.728B, resulting in a current ratio of 0.74 — well below 1.0. This means CLX's short-term obligations significantly exceed its liquid assets, creating potential refinancing or liquidity pressure.
来源: 10-Q Balance Sheet & Key Ratios
Net income fell 18.7% YoY to $157M while revenue declined only 0.8%, indicating that cost pressures and/or below-the-line items (interest expense on $2.486B long-term debt) are disproportionately eroding profitability. EPS dropped 16.8% to $1.29 on a basic basis.
来源: 10-Q Income Statement
Cash and equivalents declined 21.7% YoY to $227M from $290M, even as operating cash flow remained stable. This reduction, combined with elevated current liabilities, narrows the company's liquidity buffer for unexpected operational or market disruptions.
来源: 10-Q Balance Sheet & Cash Flow Statement
Cost of revenue increased 0.3% YoY despite a 0.8% revenue decline, compressing gross margin to 43.16% from 43.77%. If commodity or supply chain costs remain elevated, further margin erosion could pressure CLX's ability to sustain profitability.
来源: 10-Q Income Statement & Key Ratios
| 指标 | 当期 | 上期 | 同比变化 |
|---|---|---|---|
营收 亿美元 | 16.73 亿美元 | 16.86 亿美元 | -0.77% |
营业成本 亿美元 | 9.51 亿美元 | 9.48 亿美元 | +0.32% |
毛利润 亿美元 | 7.22 亿美元 | 7.38 亿美元 | -2.17% |
净利润 亿美元 | 1.57 亿美元 | 1.93 亿美元 | -18.65% |
每股收益（基本） 美元 | 1.29 美元 | 1.55 美元 | -16.77% |
每股收益（稀释） 美元 | 1.29 美元 | 1.54 美元 | -16.23% |
研发费用 万美元 | 2900.00 万美元 | 3100.00 万美元 | -6.45% |
销售及管理费用 亿美元 | 2.62 亿美元 | 2.80 亿美元 | -6.43% |
答案基于本次 SEC 报告与本页数据